Prion disease tempo determined by host-dependent substrate reduction
Authors:
- Charles E. MaysCMCharles E. Mays
- Chae KimCKChae Kim
- Tracy HaldimanTHTracy Haldiman
- Jacques van der MerweJMJacques van der Merwe
- Agnes LauALAgnes Lau
- Jing YangJYJing Yang
- Jennifer GramsJGJennifer Grams
- Michele A. Di BariMBMichele A. Di Bari
- Romolo NonnoRNRomolo Nonno
- Glenn C. TellingGTGlenn C. Telling
- Qingzhong KongQKQingzhong Kong
- Jan LangeveldJLJan Langeveld
Open Access
- 16 January 2014
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 124 (2) , 847-858
Abstract
The symptoms of prion infection can take years or decades to manifest following the initial exposure. Molecular markers of prion disease include accumulation of the misfolded prion protein (PrPSc), which is derived from its cellular precursor (PrPC), as well as downregulation of the PrP-like Shadoo (Sho) glycoprotein. Given the overlapping cellular environments for PrPC and Sho, we inferred that PrPC levels might also be altered as part of a host response during prion infection. Using rodent models, we found that, in addition to changes in PrPC glycosylation and proteolytic processing, net reductions in PrPC occur in a wide range of prion diseases, including sheep scrapie, human Creutzfeldt-Jakob disease, and cervid chronic wasting disease. The reduction in PrPC results in decreased prion replication, as measured by the protein misfolding cyclic amplification technique for generating PrPSc in vitro. While PrPC downregulation is not discernible in animals with unusually short incubation periods and high PrPC expression, slowly evolving prion infections exhibit downregulation of the PrPC substrate required for new PrPSc synthesis and as a receptor for pathogenic signaling. Our data reveal PrPC downregulation as a previously unappreciated element of disease pathogenesis that defines the extensive, presymptomatic period for many prion strains.Keywords
This publication has 67 references indexed in Scilit:
- Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acidsProceedings of the National Academy of Sciences, 2012
- Sustained translational repression by eIF2α-P mediates prion neurodegenerationNature, 2012
- Agent-specific Shadoo Responses in Transmissible EncephalopathiesJournal of Neuroimmune Pharmacology, 2010
- Enhancement of protein misfolding cyclic amplification by using concentrated cellular prion protein sourceBiochemical and Biophysical Research Communications, 2009
- Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt–Jakob diseaseLaboratory Investigation, 2009
- Cell‐free propagation of prion strainsThe EMBO Journal, 2008
- Prion strain discrimination in cell culture: The cell panel assayProceedings of the National Academy of Sciences, 2007
- The CNS glycoprotein Shadoo has PrPC‐like protective properties and displays reduced levels in prion infectionsThe EMBO Journal, 2007
- Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassayBiochemical Journal, 2006
- The most infectious prion protein particlesNature, 2005